215380 — Woojung BIO Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Woojung BIO, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	R2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Interim Report	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	15,122	15,793	6,746	4,820	5,566
Net Total Accounts Receivable
Net Total Receivables	2,946	4,535	5,758	2,149	7,181
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	33,457	28,250	25,169	13,887	19,690
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	19,297	35,650	57,281	63,715	56,130
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	57,632	69,816	100,136	94,994	98,333
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	27,992	22,581	38,010	45,244	45,699
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	30,971	41,785	68,676	65,275	76,361
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Other Equity
Total Equity	26,661	28,031	31,460	29,718	21,972
Total Liabilities & Shareholders' Equity	57,632	69,816	100,136	94,994	98,333
Total Common Shares Outstanding
Total Preferred Shares Outstanding